SPS3 Evidence Supports Intensive Blood Pressure Control

Por Oparil, Suzanne
Publicado no Circulation (2016)

Fixed combinations in the management of hypertension: patient perspectives and rationale for development and utility of the olmesartan – amlodipine combination

Por Pimenta, Eduardo, Oparil, Suzanne
Publicado em 2008

Role of aliskiren in cardio-renal protection and use in hypertensives with multiple risk factors

Por Pimenta, Eduardo, Oparil, Suzanne
Publicado em 2009

Role of aliskiren in cardio-renal protection and use in hypertensives with multiple risk factors

Por Pimenta, Eduardo, Oparil, Suzanne
Publicado em 2009

Impact of olmesartan on blood pressure, endothelial function, and cardiovascular outcomes

Por Pimenta, Eduardo, Oparil, Suzanne
Publicado em 2010

J Curve in Hypertension

Por Dudenbostel, Tanja, Oparil, Suzanne
Publicado no Curr Cardiovasc Risk Rep (2012)

Hypertension: What It Is; What It Isn't; How to Think About It, to Prevent It, and to Manage It

Por Oparil, Suzanne, Lundberg, George D.
Publicado em 2007

Novel strategies for treatment of resistant hypertension

Por Judd, Eric K, Oparil, Suzanne
Publicado em 2013

Should patients with cardiovascular risk factors receive intensive treatment of hypertension to < 120/80 mm Hg target?: A protagonist view from SPRINT

Por Oparil, Suzanne, Lewis, Cora E.
Publicado no Circulation (2016)

`Complementary peptides': a response

Por Blalock, J. Edwin, Elton, Terry S., Oparil, Suzanne
Publicado em 1989

Decrease in Peripheral Sympathetic Nervous System Activity following Renal Denervation or Unclipping in the One-Kidney One-Clip Goldblatt Hypertensive Rat

Por Katholi, Richard E., Winternitz, Sherry R., Oparil, Suzanne
Publicado em 1982

Role of the Renal Sympathetic Nerves in the Development and Maintenance of Hypertension in the Spontaneously Hypertensive Rat

Por Winternitz, Sherry R., Katholi, Richard E., Oparil, Suzanne
Publicado em 1980

Mechanism of postarrhythmic renal vasoconstriction in the anesthetized dog.

Por Katholi, R E, Oparil, S, Urthaler, F, James, T N
Publicado em 1979

Atrial natriuretic peptide regulation of noradrenaline release in the anterior hypothalamic area of spontaneously hypertensive rats.

Por Peng, N, Oparil, S, Meng, Q C, Wyss, J M
Publicado em 1996

REFRACTORY HYPERTENSION: A NOVEL PHENOTYPE OF ANTIHYPERTENSIVE TREATMENT FAILURE

Por Dudenbostel, Tanja, Siddiqui, Mohammed, Oparil, Suzanne, Calhoun, David A.
Publicado no Hypertension (2016)

Long-term efficacy of a combination of amlodipine and olmesartan medoxomil±hydrochlorothiazide in patients with hypertension stratified by age, race and diabetes status: a substudy...

Por Oparil, S, Chrysant, S G, Melino, M, Lee, J, Karki, S, Heyrman, R
Publicado em 2010

Hypertension in women

Por Hage, Fadi G, Mansur, Sulaf J, Xing, Dongqi, Oparil, Suzanne
Publicado em 2013

Prevalence of pseudoresistant hypertension due to inaccurate blood pressure measurement

Por Bhatt, Hemal, Siddiqui, Mohammed, Judd, Eric, Oparil, Suzanne, Calhoun, David
Publicado no J Am Soc Hypertens (2016)

Cardiovascular care for older adults: hypertension and stroke in the older adult

Por Miller, Andrew P, Navar, Ann M, Roubin, Gary S, Oparil, Suzanne
Publicado no J Geriatr Cardiol (2016)

White coat effect is uncommon in patients with refractory hypertension

Por Siddiqui, Mohammed, Judd, Eric K., Oparil, Suzanne, Calhoun, David A.
Publicado no Hypertension (2017)